Research Overview: Nolvabolic Tamoxifen
Nolvabolic (Tamoxifen) is a non-steroidal selective estrogen receptor modulator developed by Cooper Pharma for advanced laboratory investigation. This extensively studied SERM demonstrates complex tissue-selective activity, functioning as an estrogen antagonist in certain tissues while exhibiting agonist properties in others. Research scientists at Stroid UK Shop examine tamoxifen’s dual-mechanism receptor binding for understanding hormonal pathway regulation. The compound’s well-characterised pharmacological profile makes it an essential reference standard in endocrine research protocols worldwide.
Laboratory Research Applications
Researchers investigate Nolvabolic’s tissue-selective estrogen receptor modulation across multiple experimental frameworks. Cell culture studies examine its competitive antagonism at hypothalamic estrogen receptors and subsequent effects on gonadotropin signalling cascades. Scientists analyse tamoxifen’s interaction with estrogen response elements in gene transcription models, particularly studying differential tissue responses in breast, bone, and endometrial cell lines. The compound serves as a critical control in aromatase inhibitor research comparing SERM versus AI mechanisms. Advanced laboratories incorporate Nolvabolic into receptor binding assays, investigating structure-activity relationships alongside other selective modulators from our SARMs collection and peptide research compounds.
Technical Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | (Z)-2-[4-(1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine citrate |
| CAS Number | 54965-24-1 (citrate salt) |
| Molecular Formula | C₃₂H₃₇NO₈ |
| Molecular Weight | 563.64 g/mol |
| Purity | Verify with supplier |
| Form | Oral tablets |
| Storage | Room temperature, protect from light |
| Solubility | Poorly water-soluble, ethanol-soluble |
Research Compliance Statement
Nolvabolic (Tamoxifen) Cooper Pharma is manufactured exclusively for in-vitro laboratory research applications and scientific investigation. This research chemical is not intended for human consumption, therapeutic use, or any non-research purposes. Researchers must maintain appropriate laboratory safety protocols and comply with institutional research guidelines when handling this compound. Cooper Pharma maintains strict quality control standards for research-grade materials, though end-users should verify specifications through independent analytical testing.
